Traders bought shares of Colgate-Palmolive (NYSE:CL) on weakness during trading hours on Monday. $50.69 million flowed into the stock on the tick-up and $23.72 million flowed out of the stock on the tick-down, for a money net flow of $26.97 million into the stock. Of all equities tracked, Colgate-Palmolive had the 26th highest net in-flow for the day. Colgate-Palmolive traded down ($0.91) for the day and closed at $66.29
CL has been the topic of a number of recent analyst reports. Zacks Investment Research raised Colgate-Palmolive from a “strong sell” rating to a “hold” rating in a research report on Tuesday, December 11th. Goldman Sachs Group raised Colgate-Palmolive from a “neutral” rating to a “buy” rating in a research report on Tuesday, January 8th. Evercore ISI assumed coverage on Colgate-Palmolive in a research report on Thursday, January 10th. They issued an “outperform” rating and a $70.00 target price on the stock. Wells Fargo & Co reiterated a “hold” rating and issued a $57.00 price target on shares of Colgate-Palmolive in a report on Friday, January 25th. Finally, Morgan Stanley set a $62.00 price target on Colgate-Palmolive and gave the company a “hold” rating in a report on Tuesday, January 29th. Three analysts have rated the stock with a sell rating, twelve have given a hold rating and four have given a buy rating to the company. Colgate-Palmolive has a consensus rating of “Hold” and a consensus target price of $65.13.
The company has a debt-to-equity ratio of 32.25, a current ratio of 1.14 and a quick ratio of 0.76. The firm has a market cap of $57.90 billion, a price-to-earnings ratio of 22.32, a P/E/G ratio of 4.25 and a beta of 0.78.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 25th. The company reported $0.74 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a return on equity of 25,268.29% and a net margin of 15.44%. The business had revenue of $3.81 billion during the quarter, compared to the consensus estimate of $3.78 billion. During the same period in the previous year, the business earned $0.75 EPS. The business’s quarterly revenue was down 2.1% on a year-over-year basis. Sell-side analysts expect that Colgate-Palmolive will post 2.83 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a dividend of $0.43 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 dividend on an annualized basis and a yield of 2.59%. The ex-dividend date is Wednesday, April 17th. Colgate-Palmolive’s dividend payout ratio is presently 56.57%.
In related news, CEO Ian M. Cook sold 22,634 shares of the company’s stock in a transaction on Tuesday, February 19th. The stock was sold at an average price of $66.31, for a total transaction of $1,500,860.54. Following the completion of the transaction, the chief executive officer now directly owns 1,162,793 shares in the company, valued at approximately $77,104,803.83. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, COO Noel R. Wallace sold 4,541 shares of the company’s stock in a transaction on Tuesday, February 19th. The stock was sold at an average price of $66.43, for a total value of $301,658.63. Following the transaction, the chief operating officer now owns 186,380 shares of the company’s stock, valued at $12,381,223.40. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 51,700 shares of company stock valued at $3,419,284. 1.02% of the stock is owned by company insiders.
Institutional investors and hedge funds have recently modified their holdings of the stock. MML Investors Services LLC grew its stake in shares of Colgate-Palmolive by 52.0% in the third quarter. MML Investors Services LLC now owns 35,203 shares of the company’s stock worth $2,357,000 after purchasing an additional 12,045 shares in the last quarter. Cedar Capital LLC acquired a new stake in Colgate-Palmolive during the 3rd quarter worth about $209,000. AXA boosted its position in shares of Colgate-Palmolive by 75.8% during the 3rd quarter. AXA now owns 826,108 shares of the company’s stock worth $55,308,000 after purchasing an additional 356,290 shares in the last quarter. Janus Henderson Group PLC boosted its position in shares of Colgate-Palmolive by 16.6% during the 3rd quarter. Janus Henderson Group PLC now owns 461,370 shares of the company’s stock worth $30,888,000 after purchasing an additional 65,628 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its position in shares of Colgate-Palmolive by 1.1% during the 3rd quarter. Bank of New York Mellon Corp now owns 20,359,199 shares of the company’s stock worth $1,363,050,000 after purchasing an additional 223,814 shares in the last quarter. Hedge funds and other institutional investors own 75.02% of the company’s stock.
About Colgate-Palmolive (NYSE:CL)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
Further Reading: What is the NASDAQ?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.